Selection and characterization of L1210 sublines resistant to teniposide (VM-26)

Two spectra of L1210 sublines with gradations of resistance to teniposide (VM-26) were selected by stepwise exposure of cultures to increasing concentrations of the drug. Cultures representing the first spectrum were from 20 times to 1200 times more resistant to VM-26 than were cultures of parental...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer research (Chicago, Ill.) Ill.), 1984-07, Vol.44 (7), p.2981-2985
Hauptverfasser: LEE, T, ROBERTS, D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2985
container_issue 7
container_start_page 2981
container_title Cancer research (Chicago, Ill.)
container_volume 44
creator LEE, T
ROBERTS, D
description Two spectra of L1210 sublines with gradations of resistance to teniposide (VM-26) were selected by stepwise exposure of cultures to increasing concentrations of the drug. Cultures representing the first spectrum were from 20 times to 1200 times more resistant to VM-26 than were cultures of parental cells. At 24 hr after addition of 22 nM VM-26 to the medium, the growth of cultures of parental cells was inhibited by 50%. Increases in resistance to VM-26 among the sublines coincided with increases in population doubling times. When cells were transferred to drug-free medium, there was a sharp decrease in resistance over the first 10 days; the subsequent decline in resistance, over 2 to 4 months, correlated with a decrease in population doubling times. The second spectrum of resistant sublines arose from the first spectrum after the latter had been maintained for about 1 year on various selective concentrations of VM-26. Resistance to VM-26 by this second group of sublines was from 400 times to over 2000 times greater than that of the parental cell line. Doubling times for these resistant cell populations were similar to the normal rate of the parental cell line. Eight sublines were characterized by two chromosomes with homogeneously staining regions, while the remaining subline had a single chromosome with this anomaly. One of the regions appeared on a submetacentric chromosome in seven of the nine sublines, while the other was on an acrocentric chromosome. These observations indicate that a longer doubling time facilitated selection of increasingly resistant sublines but was not essential for the resistance of sublines in the second spectrum.
format Article
fullrecord <record><control><sourceid>pubmed_pasca</sourceid><recordid>TN_cdi_pubmed_primary_6722821</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>6722821</sourcerecordid><originalsourceid>FETCH-LOGICAL-h268t-5971c9763fab65f097aebf65e60ab517354b73239529fbe3b7953224c45d57953</originalsourceid><addsrcrecordid>eNo9T8tKxDAUDaKMdfQThCxc6KKQR2_SLGXwBRUFH9vhJk2YSKctTWahX--oxdV5cuAckIKDrEtdVXBICsZYXUKlxTE5SeljL4EzWJCF0kLUghfk-cV33uU49BT7lroNTuiyn-IX_ppDoA0XnNG0s13sfaKTTzFl7DPNA82-j-OQYuvp5ftjKdTVKTkK2CV_NuOSvN3evK7uy-bp7mF13ZQboepcgtHcGa1kQKsgMKPR26DAK4YWuJZQWS2FNCBMsF5abUAKUbkKWvjhS3L-tzvu7Na363GKW5w-1_OzfX4x55gcdmHC3sX0X6trLZnh8hscS1W5</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Selection and characterization of L1210 sublines resistant to teniposide (VM-26)</title><source>MEDLINE</source><source>American Association for Cancer Research</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>LEE, T ; ROBERTS, D</creator><creatorcontrib>LEE, T ; ROBERTS, D</creatorcontrib><description>Two spectra of L1210 sublines with gradations of resistance to teniposide (VM-26) were selected by stepwise exposure of cultures to increasing concentrations of the drug. Cultures representing the first spectrum were from 20 times to 1200 times more resistant to VM-26 than were cultures of parental cells. At 24 hr after addition of 22 nM VM-26 to the medium, the growth of cultures of parental cells was inhibited by 50%. Increases in resistance to VM-26 among the sublines coincided with increases in population doubling times. When cells were transferred to drug-free medium, there was a sharp decrease in resistance over the first 10 days; the subsequent decline in resistance, over 2 to 4 months, correlated with a decrease in population doubling times. The second spectrum of resistant sublines arose from the first spectrum after the latter had been maintained for about 1 year on various selective concentrations of VM-26. Resistance to VM-26 by this second group of sublines was from 400 times to over 2000 times greater than that of the parental cell line. Doubling times for these resistant cell populations were similar to the normal rate of the parental cell line. Eight sublines were characterized by two chromosomes with homogeneously staining regions, while the remaining subline had a single chromosome with this anomaly. One of the regions appeared on a submetacentric chromosome in seven of the nine sublines, while the other was on an acrocentric chromosome. These observations indicate that a longer doubling time facilitated selection of increasingly resistant sublines but was not essential for the resistance of sublines in the second spectrum.</description><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>PMID: 6722821</identifier><identifier>CODEN: CNREA8</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Animals ; Antineoplastic agents ; Biological and medical sciences ; Cell Division - drug effects ; Chromosome Banding ; Clone Cells ; Drug Resistance ; General aspects ; Karyotyping ; Kinetics ; Leukemia L1210 - genetics ; Leukemia L1210 - physiopathology ; Medical sciences ; Metaphase ; Mice ; Mutation ; Pharmacology. Drug treatments ; Podophyllotoxin - analogs &amp; derivatives ; Teniposide - toxicity</subject><ispartof>Cancer research (Chicago, Ill.), 1984-07, Vol.44 (7), p.2981-2985</ispartof><rights>1985 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=8873091$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6722821$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>LEE, T</creatorcontrib><creatorcontrib>ROBERTS, D</creatorcontrib><title>Selection and characterization of L1210 sublines resistant to teniposide (VM-26)</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description>Two spectra of L1210 sublines with gradations of resistance to teniposide (VM-26) were selected by stepwise exposure of cultures to increasing concentrations of the drug. Cultures representing the first spectrum were from 20 times to 1200 times more resistant to VM-26 than were cultures of parental cells. At 24 hr after addition of 22 nM VM-26 to the medium, the growth of cultures of parental cells was inhibited by 50%. Increases in resistance to VM-26 among the sublines coincided with increases in population doubling times. When cells were transferred to drug-free medium, there was a sharp decrease in resistance over the first 10 days; the subsequent decline in resistance, over 2 to 4 months, correlated with a decrease in population doubling times. The second spectrum of resistant sublines arose from the first spectrum after the latter had been maintained for about 1 year on various selective concentrations of VM-26. Resistance to VM-26 by this second group of sublines was from 400 times to over 2000 times greater than that of the parental cell line. Doubling times for these resistant cell populations were similar to the normal rate of the parental cell line. Eight sublines were characterized by two chromosomes with homogeneously staining regions, while the remaining subline had a single chromosome with this anomaly. One of the regions appeared on a submetacentric chromosome in seven of the nine sublines, while the other was on an acrocentric chromosome. These observations indicate that a longer doubling time facilitated selection of increasingly resistant sublines but was not essential for the resistance of sublines in the second spectrum.</description><subject>Animals</subject><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>Cell Division - drug effects</subject><subject>Chromosome Banding</subject><subject>Clone Cells</subject><subject>Drug Resistance</subject><subject>General aspects</subject><subject>Karyotyping</subject><subject>Kinetics</subject><subject>Leukemia L1210 - genetics</subject><subject>Leukemia L1210 - physiopathology</subject><subject>Medical sciences</subject><subject>Metaphase</subject><subject>Mice</subject><subject>Mutation</subject><subject>Pharmacology. Drug treatments</subject><subject>Podophyllotoxin - analogs &amp; derivatives</subject><subject>Teniposide - toxicity</subject><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1984</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9T8tKxDAUDaKMdfQThCxc6KKQR2_SLGXwBRUFH9vhJk2YSKctTWahX--oxdV5cuAckIKDrEtdVXBICsZYXUKlxTE5SeljL4EzWJCF0kLUghfk-cV33uU49BT7lroNTuiyn-IX_ppDoA0XnNG0s13sfaKTTzFl7DPNA82-j-OQYuvp5ftjKdTVKTkK2CV_NuOSvN3evK7uy-bp7mF13ZQboepcgtHcGa1kQKsgMKPR26DAK4YWuJZQWS2FNCBMsF5abUAKUbkKWvjhS3L-tzvu7Na363GKW5w-1_OzfX4x55gcdmHC3sX0X6trLZnh8hscS1W5</recordid><startdate>19840701</startdate><enddate>19840701</enddate><creator>LEE, T</creator><creator>ROBERTS, D</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>19840701</creationdate><title>Selection and characterization of L1210 sublines resistant to teniposide (VM-26)</title><author>LEE, T ; ROBERTS, D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h268t-5971c9763fab65f097aebf65e60ab517354b73239529fbe3b7953224c45d57953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1984</creationdate><topic>Animals</topic><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>Cell Division - drug effects</topic><topic>Chromosome Banding</topic><topic>Clone Cells</topic><topic>Drug Resistance</topic><topic>General aspects</topic><topic>Karyotyping</topic><topic>Kinetics</topic><topic>Leukemia L1210 - genetics</topic><topic>Leukemia L1210 - physiopathology</topic><topic>Medical sciences</topic><topic>Metaphase</topic><topic>Mice</topic><topic>Mutation</topic><topic>Pharmacology. Drug treatments</topic><topic>Podophyllotoxin - analogs &amp; derivatives</topic><topic>Teniposide - toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>LEE, T</creatorcontrib><creatorcontrib>ROBERTS, D</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>LEE, T</au><au>ROBERTS, D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Selection and characterization of L1210 sublines resistant to teniposide (VM-26)</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>1984-07-01</date><risdate>1984</risdate><volume>44</volume><issue>7</issue><spage>2981</spage><epage>2985</epage><pages>2981-2985</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><coden>CNREA8</coden><abstract>Two spectra of L1210 sublines with gradations of resistance to teniposide (VM-26) were selected by stepwise exposure of cultures to increasing concentrations of the drug. Cultures representing the first spectrum were from 20 times to 1200 times more resistant to VM-26 than were cultures of parental cells. At 24 hr after addition of 22 nM VM-26 to the medium, the growth of cultures of parental cells was inhibited by 50%. Increases in resistance to VM-26 among the sublines coincided with increases in population doubling times. When cells were transferred to drug-free medium, there was a sharp decrease in resistance over the first 10 days; the subsequent decline in resistance, over 2 to 4 months, correlated with a decrease in population doubling times. The second spectrum of resistant sublines arose from the first spectrum after the latter had been maintained for about 1 year on various selective concentrations of VM-26. Resistance to VM-26 by this second group of sublines was from 400 times to over 2000 times greater than that of the parental cell line. Doubling times for these resistant cell populations were similar to the normal rate of the parental cell line. Eight sublines were characterized by two chromosomes with homogeneously staining regions, while the remaining subline had a single chromosome with this anomaly. One of the regions appeared on a submetacentric chromosome in seven of the nine sublines, while the other was on an acrocentric chromosome. These observations indicate that a longer doubling time facilitated selection of increasingly resistant sublines but was not essential for the resistance of sublines in the second spectrum.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>6722821</pmid><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0008-5472
ispartof Cancer research (Chicago, Ill.), 1984-07, Vol.44 (7), p.2981-2985
issn 0008-5472
1538-7445
language eng
recordid cdi_pubmed_primary_6722821
source MEDLINE; American Association for Cancer Research; EZB-FREE-00999 freely available EZB journals
subjects Animals
Antineoplastic agents
Biological and medical sciences
Cell Division - drug effects
Chromosome Banding
Clone Cells
Drug Resistance
General aspects
Karyotyping
Kinetics
Leukemia L1210 - genetics
Leukemia L1210 - physiopathology
Medical sciences
Metaphase
Mice
Mutation
Pharmacology. Drug treatments
Podophyllotoxin - analogs & derivatives
Teniposide - toxicity
title Selection and characterization of L1210 sublines resistant to teniposide (VM-26)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T06%3A12%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Selection%20and%20characterization%20of%20L1210%20sublines%20resistant%20to%20teniposide%20(VM-26)&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=LEE,%20T&rft.date=1984-07-01&rft.volume=44&rft.issue=7&rft.spage=2981&rft.epage=2985&rft.pages=2981-2985&rft.issn=0008-5472&rft.eissn=1538-7445&rft.coden=CNREA8&rft_id=info:doi/&rft_dat=%3Cpubmed_pasca%3E6722821%3C/pubmed_pasca%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/6722821&rfr_iscdi=true